Skip to main content
. 2022 Jun 16;10:902123. doi: 10.3389/fpubh.2022.902123

Figure 5.

Figure 5

Results of the molecular docking of the potential predicted drugs. Further, it shows the molecular interaction, residues, and scores. (A,B) It shows the interaction of Adaptor Protein 2-Associated Kinase 1 (AAK1) with Balaglitazone, Cortivazol, and Velusetrag, respectively. The docking score of the small molecules is −9.9 for the first two and −19.1 for Velusetrag which suggests strong binding affinity during the interaction. Additionally, in (C,D) interaction of Cyclin-G-associated kinase with Balaglitazone and Velusetrag is shown, respectively, with docking scores of −9.6 and −10.0. Whereas (E), shows the molecular interaction between Angiotensin-converting enzyme 2 (ACE2) and Cortivazol with a docking score of −10 followed by (F–H) Cortivazol, 16 alpha-Bromoepiandrosterone, and Balaglitazone results with Furin. The docking score for Furin-Cortivazol complex is −9.4, for Furin-16 alpha-Bromoepiandrosterone, the docking score is −8.7, and for Furin-Balaglitazone, the docking score is −9.1. (I) Cortivazol binding affinity with Adaptor Protein 2-Associated Kinase 1 (AAK1).